Skinner M P, Fournier D J, Andrews R K, Gorman J J, Chesterman C N, Berndt M C
Research Centre for Thrombosis and Cardiovascular Disease, Department of Medicine, Westmead Hospital, N.S.W., Australia.
Biochem Biophys Res Commun. 1989 Nov 15;164(3):1373-9. doi: 10.1016/0006-291x(89)91821-4.
Human platelet GMP-140 has been identified as a heparin-binding protein. Purified platelet GMP-140 bound to Heparin-Sepharose CL-6B and was eluted by approximately 0.5 M sodium chloride. Radioiodinated GMP-140 bound specifically and saturably to heparin immobilized on Matrex-Pel 102 beads. Binding of radioiodinated GMP-140 to heparin-Matrex-Pel 102 beads was divalent cation-independent and was strongly inhibited by excess fluid phase GMP-140 and heparin and by other sulfated glycans such as fucoidin and dextran-sulfate. Binding was not inhibited by chondroitins 4- and 6-sulfate or mannose 6-phosphate.
人血小板GMP - 140已被鉴定为一种肝素结合蛋白。纯化的血小板GMP - 140与肝素 - 琼脂糖CL - 6B结合,并通过约0.5M氯化钠洗脱。放射性碘化的GMP - 140特异性且饱和地结合到固定在Matrex - Pel 102珠上的肝素上。放射性碘化的GMP - 140与肝素 - Matrex - Pel 102珠的结合不依赖二价阳离子,且受到过量液相GMP - 140、肝素以及其他硫酸化聚糖(如岩藻依聚糖和硫酸葡聚糖)的强烈抑制。硫酸软骨素4 - 硫酸酯和6 - 硫酸酯或甘露糖6 - 磷酸不抑制结合。